Financials
- Market Capitalization 4.65 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-9.81
売上高対価格比率
781.65
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1303 | TVTX Travere Therapeutics, Inc. - Common Stock | 52.62 USD | +0.94% | -8.66% | -20.48% | +82.90% | 4.96 B USD | ||
| 1326 | DFTX Definium Therapeutics, Inc. - Common Shares | 35.21 USD | -4.58% | -3.56% | -19.06% | +133.02% | 4.73 B USD | ||
| 1418 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.15 USD | +0.23% | -3.95% | -10.98% | +157.06% | 4.25 B USD | ||
| 1439 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.46 USD | -3.89% | -11.93% | +4.95% | +47.51% | 4.06 B USD |